Iradimed 13G/A: Family trusts report 34.8% stake
Iradimed Corporation Amendment No. 3 to a Schedule 13G/A discloses beneficial ownership positions held by Roger E. Susi and related trusts.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Iradimed Corporation Amendment No. 3 to a Schedule 13G/A discloses beneficial ownership positions held by Roger E. Susi and related trusts. The filing reports 4,450,450 shares beneficially owned in aggregate, equal to 34.8% of common stock based on April 30, 2026 outstanding shares.
The disclosure breaks ownership into: 162,950 shares held by the Roger E. Susi Revocable Trust, 2,062,500 shares held by the Matthew Susi 2008 Dynasty Trust, and 2,225,000 shares held by the Phillip Susi 2008 Dynasty Trust. It reports voting and dispositive power allocations and identifies trustees and settlor relationships.
Insights
Family trusts control a material minority stake with combined voting influence.
The filing shows a combined beneficial position of 4,450,450 shares, or 34.8%, calculated on April 30, 2026. Reported allocations list sole voting/dispositive power for the settlor's revocable trust and sole powers for two dynasty trusts; a separate trustee holds shared power for the dynasty trusts.
These ownership and voting allocations matter for board influence and proxy outcomes. Subsequent filings or any sales by these holders would change the ownership profile recorded here.
Amendment clarifies beneficial ownership and power-of-vote breakdowns across related trusts.
The statement references 12,783,035 shares outstanding as of April 30, 2026 as the base for percentage calculations. It identifies the settlor and trustee roles for each trust and quantifies sole versus shared voting and dispositive powers by reporting person.
Filing mechanics: this is an amended Schedule 13G/A under passive/beneficial ownership reporting rules; any change in voting or disposition would require further amendment.
Key Figures
Key Terms
Beneficial owner regulatory
Settlor legal
SCHEDULE 13G/A regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How are voting and dispositive powers allocated among the Susi reporting persons?
Which entities are identified as trustees or settlors in the Schedule 13G/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.